Literature DB >> 9157154

Propagation of granulocytic Ehrlichia spp. from human and equine sources in HL-60 cells induced to differentiate into functional granulocytes.

R Heimer1, A Van Andel, G P Wormser, M L Wilson.   

Abstract

Ehrlichia spp. from human and equine sources in the northeastern Unites States were detected by PCR, isolated, and propagated in the HL-60 promyelocytic leukemia cell line. Growth of Ehrlichia from both equine and human sources was enhanced by addition of retinoic acid, which causes granulocytic differentiation of the HL-60 cells. DNA sequencing of a portion of the 16S rDNA gene supported the hypothesis that the same pathogen was responsible for both equine and human granulocytic ehrlichiosis.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9157154      PMCID： PMC229702          DOI： 10.1128/jcm.35.4.923-927.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

1.  Equine granulocytic ehrlichiosis in Connecticut caused by an agent resembling the human granulocytotropic ehrlichia.

Authors:  J E Madigan; J E Barlough; J S Dumler; N S Schankman; E DeRock
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

2.  16S rRNA phylogenetic analysis of the bacterial endosymbionts associated with cytoplasmic incompatibility in insects.

Authors:  S L O'Neill; R Giordano; A M Colbert; T L Karr; H M Robertson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

3.  Control of HL-60 monocytic differentiation. Different pathways and uncoupled expression of differentiation markers.

Authors:  A Yen; D Brown; J Fishbaugh
Journal:  Exp Cell Res       Date:  1987-01       Impact factor: 3.905

Review 4.  The tribe Ehrlichieae and ehrlichial diseases.

Authors:  Y Rikihisa
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

5.  Ehrlichia chaffeensis, a new species associated with human ehrlichiosis.

Authors:  B E Anderson; J E Dawson; D C Jones; K H Wilson
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

6.  Direct cultivation of the causative agent of human granulocytic ehrlichiosis.

Authors:  J L Goodman; C Nelson; B Vitale; J E Madigan; J S Dumler; T J Kurtti; U G Munderloh
Journal:  N Engl J Med       Date:  1996-01-25       Impact factor: 91.245

7.  Identification of the causative agent of granulocytic ehrlichiosis in Swedish dogs and horses by direct solid phase sequencing of PCR products from the 16S rRNA gene.

Authors:  K E Johansson; B Pettersson; M Uhlén; A Gunnarsson; M Malmqvist; E Olsson
Journal:  Res Vet Sci       Date:  1995-03       Impact factor: 2.534

8.  Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid.

Authors:  T R Breitman; S E Selonick; S J Collins
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

9.  Ixodes dammini as a potential vector of human granulocytic ehrlichiosis.

Authors:  P Pancholi; C P Kolbert; P D Mitchell; K D Reed; J S Dumler; J S Bakken; S R Telford; D H Persing
Journal:  J Infect Dis       Date:  1995-10       Impact factor: 5.226

Review 10.  Emergence of the ehrlichioses as human health problems.

Authors:  D H Walker; J S Dumler
Journal:  Emerg Infect Dis       Date:  1996 Jan-Mar       Impact factor: 6.883
View more
  12 in total

1.  Granulocytic ehrlichiosis in mice deficient in phagocyte oxidase or inducible nitric oxide synthase.

Authors:  R Banerjee; J Anguita; E Fikrig
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

2.  Citrate synthase gene sequence: a new tool for phylogenetic analysis and identification of Ehrlichia.

Authors:  H Inokuma; P Brouqui; M Drancourt; D Raoult
Journal:  J Clin Microbiol       Date:  2001-09       Impact factor: 5.948

3.  Human exposure to a granulocytic Ehrlichia and other tick-borne agents in Connecticut.

Authors:  L A Magnarelli; J W Ijdo; J F Anderson; S J Padula; R A Flavell; E Fikrig
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

4.  Nested PCR assay for detection of granulocytic ehrlichiae.

Authors:  R F Massung; K Slater; J H Owens; W L Nicholson; T N Mather; V B Solberg; J G Olson
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

5.  Anaplasma phagocytophilum dense-cored organisms mediate cellular adherence through recognition of human P-selectin glycoprotein ligand 1.

Authors:  Matthew J Troese; Jason A Carlyon
Journal:  Infect Immun       Date:  2009-07-13       Impact factor: 3.441

6.  Sodium valproate facilitates the propagation of granulocytic ehrlichiae (Anaplasma phagocytophilum) in HL-60 cells.

Authors:  Petir Zeman; Jaroslav Cinatl; Hana Kabickova
Journal:  Exp Appl Acarol       Date:  2002       Impact factor: 2.132

7.  Major surface protein 2 of Anaplasma phagocytophilum facilitates adherence to granulocytes.

Authors:  Jinho Park; Kyoung Seong Choi; J Stephen Dumler
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

8.  Monocytic differentiation inhibits infection and granulocytic differentiation potentiates infection by the agent of human granulocytic ehrlichiosis.

Authors:  M B Klein; S F Hayes; J L Goodman
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

9.  A new genetic approach to distinguish strains of Anaplasma phagocytophilum that appear not to cause human disease.

Authors:  Dionysios Liveris; Maria E Aguero-Rosenfeld; Thomas J Daniels; Sandor Karpathy; Christopher Paddock; Sahar Adish; Felicia Keesing; Richard S Ostfeld; Gary P Wormser; Ira Schwartz
Journal:  Ticks Tick Borne Dis       Date:  2021-01-19       Impact factor: 3.744

10.  Proteomic analysis of Anaplasma phagocytophilum during infection of human myeloid cells identifies a protein that is pronouncedly upregulated on the infectious dense-cored cell.

Authors:  Matthew J Troese; Amandeep Kahlon; Stephanie A Ragland; Andrew K Ottens; Nore Ojogun; Kristina T Nelson; Naomi J Walker; Dori L Borjesson; Jason A Carlyon
Journal:  Infect Immun       Date:  2011-08-15       Impact factor: 3.609
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.